[1] Brewer JR, Morrison G, Dolan ME, et al. Chemotherapy-induced peripheral neuropathy: Current status and progress [J]. Gynecol Oncol, 2016, 140(1): 176-183. [2] Cavaletti G, Alberti P, Frigeni B, et al. Chemotherapy induced neuropathy [J]. Curr Treat Options Neurol, 2011, 13(2): 180-190. [3] Dawn LH, Joseph MU, Katherine DC, et al. Randomized double-blind placebo-controlled trial of acetyl-l-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy [J]. J Clin Oncol, 2013, 31(20): 2627-2633. [4] Driessen CM, Vingerhoets AJ, Mols F, et al. Assessing the impact of chemotherapy induced peripheral neurotoxicity on the quality of life of cancer patients: the introduction of a new measure [J]. Support Care Cancer, 2012, 20(4): 877-881. [5] Sarah K, Anja W, Kathrin F, et al. Balance impairments and neuromuscular changes in breast cancer patients with chemotherapy-induced peripheral neuropathy [J]. Clin Neurophysiol, 2016, 127(2): 1481-1490. [6] Floortje M, Tonneke B, Gerard V, et al. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review [J]. Support Care Cancer, 2014, 22(8): 2261-2269. [7] Smith EM, Pang H, Cirrincione C, et al. Alliance for Clinical Trials in Oncology. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial [J]. JAMA, 2013, 309(13): 1359-1367. [8] Hirayama Y, Ishitani K, Sato Y, et al. Effect of duloxetine in Japanese patients with chemotherapy induced peripheral neuropathy: a pilot randomized trial [J]. Int J Clin Oncol, 2015, 20(5): 866-871. [9] Chu SH, Lee YJ, Lee ES, et al. Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review [J]. Support Care Cancer, 2015, 23(2): 513-524. [10] 高亚丽,陈志军,韩英民,等. 神经妥乐平治疗含紫杉醇方案化疗所致周围神经损伤的疗效观察[J]. 中国医药指南, 2013, 11(9): 156-157. [11] Schloss JM, Colosimo M, Airey C, et al. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN) [J]. Support Care Cancer, 2017, 25(1): 195-204. [12] Pace A, Giannarelli D, Galie E, et al. Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial [J]. Neurology, 2010, 74(9): 762-766. [13] 解丽,王静萱,张清媛. 化疗药物所致周围神经病变防治研究的现状[J]. 中华肿瘤防治杂志, 2013, 20(14): 1123-1126. [14] 许炜茹,花宝金. 化疗药物所致周围神经病变的中西医治疗进展[J]. 中国中西医结合杂志, 2008, 28(11): 1049-1052. [15] Han XY, Wang LJ, Shi HF, et al. Acupuncture combined with methyl cobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma [J]. BMC Cancer, 2017, 17(1): 40-46. [16] Muthuraman A, Singh N. Attenuating effect of hydroalcoholic extract of Acorus calamus in vincristine-induced painful neuropathy in rats [J]. J Nat Med, 2011, 65(3-4): 480-487. [17] Abad ANA, Nouri MHK, Tavakkoli F, et al. Effect of Salvia officinalis hydroalcoholic extract on vincristine-induced neuropathy in mice [J]. Chin J Nat Med, 2011, 9(5): 354-358. [18] 张虹,徐悦涛,张瑛. 中药外洗治疗化疗所致周围神经毒性250例疗效观察[J]. 世界中西医结合杂志, 2015, 10(4): 531-533. [19] 姜靖雯,陈学武,蔡红兵,等. 四藤一仙汤熏洗预防奥沙利铂所致周围神经毒性的临床观察[J]. 南京中医药大学学报, 2015, 31(5): 420-423. [20] Sun YY, Jia YJ, Huang MN, et al. Buyang Huanwu decoction in prevention of peripheral neuropathy after chemotherapy: a clinical observation [J]. Guangming J Chin Med, 2008, 23(7): 958-959. [21] 李凤姣,王珊. 补阳还五汤和弥可保联合中药熏蒸防治化疗后周围神经病变的临床观察及护理[J]. 湖南中医药大学学报, 2013, 33(2): 41-42. [22] 王刚,李彩霞,陈侠. 针刺结合补阳还五汤加味治疗化疗后周围神经损害32例[J]. 湖南中医杂志, 2011, 27(2): 55-56. [23] Nishioka M, Shimada M, Kurita N, et al. The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen [J]. Int J Clin Oncol, 2011, 16(4): 322-327. [24] Kono T, Mamiya N, Chisato N, et al. Efficacy of Goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer [J]. Evid Based Complement Alternat Med, 2011, 2011: 418481. [25] Kaku H, Kumagai S, Onoue H, et al. Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: a multicentre collaborative study [J]. Exp Ther Med, 2012, 3(1): 60-65. [26] Yamada T, Kan H, Matsumoto S, et al. Reduction in oxaliplatin-related neurotoxicity by the administration of Keishikajutsubuto (TJ-18) and powdered processed aconite root [J]. Gan To Kagaku Ryoho, 2012, 39(11): 1687-1691. [27] 周俭,陈鹰娜. 温经汤加减防治奥沙利铂神经毒性的临床观察[J]. 现代中西医结合杂志, 2012, 21(6): 618-619. [28] 盛军章,李庆亮,任志兵. 当归四逆汤、补阳还五汤、黄芪桂枝五物汤治疗奥沙利铂所致周围神经病变的临床对比研究[J]. 中医临床研究, 2015, 7(3): 18-20. [29] 张仲景. 金匮要略[M]. 北京:中医古籍出版社,1997: 15. [30] 吴婷婷,金燕,钟薏. 黄芪桂枝五物汤联合逆针灸对恶性肿瘤患者化疗后周围神经毒性和免疫功能的影响[J]. 山东医药, 2015, 55(33): 1-4. [31] 穆大成. 黄芪桂枝五物汤加减预防化疗后周围神经毒性临床疗效分析[J]. 亚太传统医药, 2016, 12(23): 142-143. [32] 王清任. 医林改错[M]. 天津:天津科学技术出版社, 2011: 1-50. |